Laser vs shock wave: which zaps shoulder pain better?
NCT ID NCT07667998
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will compare two non-invasive treatments—high-intensity laser therapy and extracorporeal shock wave therapy—for people with chronic supraspinatus tendinopathy (a common shoulder tendon condition). Researchers will measure tendon thickness, shoulder space, pain, range of motion, and hand strength in 69 adults aged 18 to 50. The goal is to find which therapy works better to ease symptoms and improve function.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
High-intensity laser therapy and extracorporeal shock wave therapy
What this could lead to
If this trial succeeds, it could show which non-invasive therapy better reduces tendon thickness and improves shoulder pain and function.
What could go wrong
This is a small, early-stage study with only 69 participants, so results may not apply to everyone. Both treatments are non-invasive but may not work for all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUPRASPINATUS TENDINOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••